{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:39:15Z","timestamp":1782275955674,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ackdjournal.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1053\/j.ackd.2018.10.002","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T21:16:54Z","timestamp":1552425414000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Vaccination in Chronic Kidney Disease"],"prefix":"10.1053","volume":"26","author":[{"given":"Snigdha","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrika","family":"Chitturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ackd.2018.10.002_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1525-139X.2004.17104.x","article-title":"The value of vaccination in chronic kidney disease","volume":"17","author":"Kausz","year":"2004","journal-title":"Semin Dial"},{"key":"10.1053\/j.ackd.2018.10.002_bib2","series-title":"2017 USRDS annual data report: Epidemiology of kidney disease in the United States","year":"2017"},{"issue":"4","key":"10.1053\/j.ackd.2018.10.002_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ncpneph0762","article-title":"Preventive health care in chronic kidney disease and end-stage renal disease","volume":"4","author":"Choudhury","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2018.10.002_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/14760584.2014.874950","article-title":"Vaccination issues in patients with chronic kidney disease","volume":"13","author":"Mathew","year":"2014","journal-title":"Expert Rev Vaccin"},{"issue":"3","key":"10.1053\/j.ackd.2018.10.002_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ckj\/sfv030","article-title":"The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease","volume":"8","author":"Vandecasteele","year":"2015","journal-title":"Clin Kidney J"},{"issue":"8","key":"10.1053\/j.ackd.2018.10.002_bib6","first-page":"492","article-title":"Immunization in the United States: recommendations, barriers, and measures to improve compliance. Part 2: adult vaccinations","volume":"41","author":"Ventola","year":"2016","journal-title":"P T"},{"issue":"1","key":"10.1053\/j.ackd.2018.10.002_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/tid.12473","article-title":"Low rates of vaccination in listed kidney transplant candidates","volume":"18","author":"Lee","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"10.1053\/j.ackd.2018.10.002_bib8","doi-asserted-by":"crossref","first-page":"e50553","DOI":"10.1371\/journal.pone.0050553","article-title":"Vaccination rates among the general adult population and high-risk groups in the United States","volume":"7","author":"Annunziata","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1053\/j.ackd.2018.10.002_bib9","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1586\/14760584.2015.1075397","article-title":"Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies","volume":"14","author":"Bitsori","year":"2015","journal-title":"Expert Rev Vaccin"},{"issue":"5","key":"10.1053\/j.ackd.2018.10.002_bib10","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2018.10.002_bib11","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/ndt\/gfh897","article-title":"The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells","volume":"20","author":"Hesselink","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ackd.2018.10.002_bib12","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1681\/ASN.2007090971","article-title":"Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients","volume":"19","author":"Litjens","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 4","key":"10.1053\/j.ackd.2018.10.002_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/ajt.12122","article-title":"Vaccination in solid organ transplantation","volume":"13","author":"Danziger-Isakov","year":"2013","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2018.10.002_bib14","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1053\/j.ajkd.2003.08.019","article-title":"Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better","volume":"42","author":"DaRoza","year":"2003","journal-title":"Am J kidney Dis"},{"issue":"12","key":"10.1053\/j.ackd.2018.10.002_bib15","doi-asserted-by":"crossref","first-page":"e113503","DOI":"10.1371\/journal.pone.0113503","article-title":"Socio-psychological factors driving adult vaccination: a qualitative study","volume":"9","author":"Wheelock","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1053\/j.ackd.2018.10.002_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1053\/j.ackd.2018.10.002_bib17","first-page":"2012","article-title":"PHS guidelines for management of occupational exposure to HBV, HCV and HIV: management of occupational blood exposures","volume":"64","author":"Preboth","year":"2001","journal-title":"Am Fam Physician"},{"issue":"RR-16","key":"10.1053\/j.ackd.2018.10.002_bib18","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recommend Rep"},{"issue":"2","key":"10.1053\/j.ackd.2018.10.002_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archinte.1979.03630390036015","article-title":"Duration of hepatitis B surface antigenemia (HBs Ag) in hemodialysis patients","volume":"139","author":"Ribot","year":"1979","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1053\/j.ackd.2018.10.002_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1440-1797.2009.01268.x","article-title":"Review article: hepatitis B and dialysis","volume":"15","author":"Edey","year":"2010","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"10.1053\/j.ackd.2018.10.002_bib21","first-page":"527","article-title":"Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patients","volume":"17","author":"Ghadiani","year":"2012","journal-title":"J Res Med Sci"},{"issue":"1","key":"10.1053\/j.ackd.2018.10.002_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000045880","article-title":"Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection","volume":"87","author":"Lewis-Ximenez","year":"2001","journal-title":"Nephron"},{"issue":"3","key":"10.1053\/j.ackd.2018.10.002_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/M17-3439","article-title":"on behalf of the Advisory Committee on Immunization Practices. Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2018","volume":"168","author":"Kim","year":"2018","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1053\/j.ackd.2018.10.002_bib24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jama.2018.1097","article-title":"A two-dose hepatitis B vaccine for adults (Heplisav-B)","volume":"319","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"10.1053\/j.ackd.2018.10.002_bib25","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1586\/14760584.2014.944508","article-title":"Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines","volume":"13","author":"Grzegorzewska","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1053\/j.ackd.2018.10.002_bib26","first-page":"269","article-title":"Seasonal influenza vaccination is associated with reduced morbidity and mortality in peritoneal dialysis patients","volume":"31","author":"Wang","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2018.10.002_bib27","doi-asserted-by":"crossref","first-page":"e58317","DOI":"10.1371\/journal.pone.0058317","article-title":"Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.ackd.2018.10.002_bib28","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1523-1755.2003.00787.x","article-title":"Influenza vaccine delivery and effectiveness in end-stage renal disease","volume":"63","author":"Gilbertson","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2018.10.002_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.ackd.2006.04.007","article-title":"Overview of vaccination in chronic kidney disease","volume":"13","author":"Kausz","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"issue":"10","key":"10.1053\/j.ackd.2018.10.002_bib30","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1600-6143.2011.03753.x","article-title":"Influenza vaccination in the organ transplant recipient: review and summary recommendations","volume":"11","author":"Kumar","year":"2011","journal-title":"Am J Transplant"},{"issue":"34","key":"10.1053\/j.ackd.2018.10.002_bib31","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1016\/j.vaccine.2011.05.099","article-title":"Invasive pneumococcal disease: association between serotype, clinical presentation and lethality","volume":"29","author":"Rodriguez","year":"2011","journal-title":"Vaccine"},{"issue":"50","key":"10.1053\/j.ackd.2018.10.002_bib32","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1016\/j.vaccine.2013.10.024","article-title":"Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions","volume":"31","author":"Cho","year":"2013","journal-title":"Vaccine"},{"issue":"40","key":"10.1053\/j.ackd.2018.10.002_bib33","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"issue":"3","key":"10.1053\/j.ackd.2018.10.002_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MAJ.0b013e3181425411","article-title":"Hepatitis A outbreak activity in the United States: responding to a vaccine-preventable disease","volume":"334","author":"Craig","year":"2007","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1053\/j.ackd.2018.10.002_bib35","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3390\/v5092106","article-title":"Varicella zoster virus (VZV)-human neuron interaction","volume":"5","author":"Baird","year":"2013","journal-title":"Viruses"},{"issue":"33","key":"10.1053\/j.ackd.2018.10.002_bib36","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR Morbidity Mortality Weekly Rep"},{"issue":"RR-04","key":"10.1053\/j.ackd.2018.10.002_bib37","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1053\/j.ackd.2018.10.002_bib38","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/ndt\/gfv432","article-title":"Zoster vaccination is associated with a reduction of zoster in elderly patients with chronic kidney disease","volume":"31","author":"Langan","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ackd.2018.10.002_bib39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559518302155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559518302155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T23:00:38Z","timestamp":1552431638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559518302155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1548559518302155"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2018.10.002","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}